SCHEMBL30133429

SCHEMBL30133429

Cc1cc(Cl)nc(N2C(=O)c3ccccc3C2=O)c1C

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
CYP3A4 P08684 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
XBP1 P17861 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NFKB1 P19838 1/20 0.39
PMP22 Q01453 1/20 0.39
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
AR P10275 2/20 0.38
ALPL P05186 1/20 0.37
RXFP1 Q9HBX9 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23860977 1.00 KMT2A (0.45) KMT2AMEN1CYP3A4KDM4ECYP1A2
SCHEMBL23860926 0.82 MEN1 (0.41) KMT2AMEN1NR1H3ARALPL
SCHEMBL30133449 0.82 MEN1 (0.41) KMT2AMEN1NR1H3ARALPL
SCHEMBL3641427 0.75 MEN1 (0.45) KMT2AMEN1CYP3A4KDM4ECYP1A2
SCHEMBL30133451 0.74 MEN1 (0.37) KMT2AMEN1CYP3A4MAPTNFKB1
SCHEMBL23861034 0.74 MEN1 (0.37) KMT2AMEN1CYP3A4MAPTNFKB1
SCHEMBL23860829 0.72 MEN1 (0.45) KMT2AMEN1KDM4ENR1H2NR1H3
SCHEMBL9837203 0.70 RXFP1 (0.38) KMT2AMEN1MAPTARALPL
SCHEMBL27510936 0.69 MEN1 (0.49) KMT2AMEN1KDM4EMAPTHPGD
SCHEMBL893875 0.69 MEN1 (0.44) KMT2AMEN1CYP3A4KDM4ENFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115605466-B Substituted oxoisoindoline compounds for the treatment of cancer 百时美施贵宝公司 2024-11-01 CN disclosed
CN-115605466-A Substituted oxoisoindoline compounds for the treatment of cancer 百时美施贵宝公司(US) 2023-01-13 CN disclosed